May 14 (Reuters) - Helix Biopharma Corp HBP.TO :
* HELIX BIOPHARMA CORP. L-DOS47 PHASE I LUNG CANCER TRIAL DATA TO BE RELEASED AT ASCO 2020
May 14 (Reuters) - Helix Biopharma Corp HBP.TO :
* HELIX BIOPHARMA CORP. L-DOS47 PHASE I LUNG CANCER TRIAL DATA TO BE RELEASED AT ASCO 2020